Biotronik announced the publication of NORDIC ICD (NO Regular Defibrillation testing In Cardioverter-Defibrillator Implantation) trial results in the European Heart Journal. The company-sponsored, randomized, controlled trial contributes to a growing body of clinical evidence suggesting that defibrillation (DF) testing during routine first implantable cardioverter-defibrillator (ICD) implantation on the left side does not lead to significant clinical benefits. These results also demonstrate the shock efficacy of Biotronik ICDs in a large, real-world population.

The U.S. Food and Drug Administration (FDA) announced it is establishing an advisory committee focused on patient engagement. The Patient Engagement Advisory Committee will provide advice on complex issues relating to medical devices, the regulation of devices and their use by patients to the FDA Commissioner.

A new guideline aimed at helping clinicians treat patients with supraventricular tachycardia, or a rapid heart rate, was released Sept. 23 by the American College of Cardiology, American Heart Association and Heart Rhythm Society.

CeloNova BioSciences Inc. announced that it has received conditional approval to start an investigational device exemption (IDE) trial to study the Cobra PzF coronary stent system in patients at high risk of bleeding.

September 23, 2015 — New research describes a method, tested in rats, that may someday allow healthcare providers to quickly scan the entire body for a blood clot. The research was presented at the 250th National Meeting & Exposition of the American Chemical Society (ACS), Aug. 16-20, in Boston.

Hansen Medical Inc. announced it will exhibit its Magellan robotic system at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Scientific Meeting Sept. 26-30 in Lisbon, Portugal. The company will showcase the Magellan 6Fr Robotic Catheter that is used by interventional radiologists in embolization procedures, and will conduct Magellan demonstrations.

ONC, Federal Health IT Strategic Plan 2015-2020, information technology, healthcare

The U.S. Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology (ONC), in collaboration with over 35 federal partners, released the updated Federal Health IT Strategic Plan 2015–2020 (Plan) September 21.
Frost & Sullivan, top medical technologies, growth, healthcare

Frost & Sullivan released its list of top medical technologies for 2015, featuring an array of sophisticated inventions in medical devices, diagnostics and imaging. These innovations have given birth to less expensive and flexible healthcare solutions; playing a critical role in managing the increasing frequency of chronic diseases around the globe.

As healthcare converts to an entirely electronic health record (EHR)-based system, it opens up new opportunities to monitor trends in population health and even identify specific patients for follow-up in targeted populations. Population health has become a major buzzword in healthcare over the past couple years, especially as more hospitals and practices come online with regional health information exchanges (HIE) and EHRs with enterprise- or health system-wide access.

CSI Africa

This workshop offers you a comprehensive overview of the most important catheter therapies of congenital, structural and valvar heart disease in children and adults. CSI Africa addresses the needs of adult and pediatric interventional cardiologists, cardiothoracic surgeons, anesthesiologists, imaging specialists and colleagues of other disciplines who wish to know more about the field. The strength of CSI Africa lies in the close interaction between conference attendees and faculty and the program will include lectures from leading experts in the field.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now